Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BSE
BlackRock New York Municipal Income Quality Trust
$14.79
$14.64
$11.95
$14.92
N/AN/A32,109 shs108,144 shs
FIL
(FIL)
$0.00
$19.21
$25.95
N/AN/AN/AN/A
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
$21.27
+3.5%
$19.53
$16.37
$27.72
$12.48B1433,213 shs408,496 shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BSE
BlackRock New York Municipal Income Quality Trust
0.00%0.00%0.00%0.00%0.00%
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
+5.17%+9.63%+9.66%+5.17%-10.07%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BSE
BlackRock New York Municipal Income Quality Trust
N/AN/AN/AN/AN/AN/AN/AN/A
FIL
(FIL)
N/AN/AN/AN/AN/AN/AN/AN/A
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
4.0115 of 5 stars
2.15.02.50.02.80.04.4

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BSE
BlackRock New York Municipal Income Quality Trust
N/AN/AN/AN/A
FIL
(FIL)
N/AN/AN/AN/A
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
2.13
Hold$24.0012.83% Upside

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BSE
BlackRock New York Municipal Income Quality Trust
N/AN/AN/AN/AN/AN/A
FIL
(FIL)
N/AN/AN/AN/AN/AN/A
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
$21.05B0.59$5.04 per share4.22$27.34 per share0.78

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BSE
BlackRock New York Municipal Income Quality Trust
N/AN/A0.00N/AN/AN/AN/AN/A
FIL
(FIL)
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
$540.07M$0.9223.1211.190.962.56%4.99%2.15%5/14/2024 (Estimated)

Latest FMS, HRR, BSE, and FIL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/20/2024Q4 2023
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
$0.36$0.47+$0.11$0.60$5.32 billion$5.37 billion

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BSE
BlackRock New York Municipal Income Quality Trust
$0.493.31%N/AN/A1 Years
FIL
(FIL)
N/AN/AN/AN/AN/A
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
$0.421.97%-5.51%45.65%N/A

Latest FMS, HRR, BSE, and FIL Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/15/2024
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
Annual$0.43702.35%5/17/20245/20/20246/3/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BSE
BlackRock New York Municipal Income Quality Trust
N/AN/AN/A
FIL
(FIL)
N/AN/AN/A
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
0.47
1.42
1.07

Ownership

Institutional Ownership

CompanyInstitutional Ownership
BSE
BlackRock New York Municipal Income Quality Trust
N/A
FIL
(FIL)
N/A
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
8.25%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
BSE
BlackRock New York Municipal Income Quality Trust
N/AN/AN/ANot Optionable
FIL
(FIL)
N/AN/AN/ANot Optionable
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
1,358586.83 millionN/AOptionable

FMS, HRR, BSE, and FIL Headlines

SourceHeadline
Fresenius Medical Care (NYSE:FMS) Shares Gap Up to $19.54Fresenius Medical Care (NYSE:FMS) Shares Gap Up to $19.54
marketbeat.com - April 22 at 12:00 PM
Fresenius Medical Care (NYSE:FMS) Sees Strong Trading VolumeFresenius Medical Care (NYSE:FMS) Sees Strong Trading Volume
marketbeat.com - April 18 at 1:56 PM
Fresenius Medical Care AG (NYSE:FMS) Plans Annual Dividend of $0.44Fresenius Medical Care AG (NYSE:FMS) Plans Annual Dividend of $0.44
marketbeat.com - April 17 at 8:55 AM
Fresenius Medical Care (NYSE:FMS) Upgraded to "Strong-Buy" by StockNews.comFresenius Medical Care (NYSE:FMS) Upgraded to "Strong-Buy" by StockNews.com
americanbankingnews.com - April 17 at 3:56 AM
Fresenius Medical Care (NYSE:FMS) Upgraded by StockNews.com to Strong-BuyFresenius Medical Care (NYSE:FMS) Upgraded by StockNews.com to Strong-Buy
marketbeat.com - April 16 at 11:04 PM
Comparing Global Cord Blood (NYSE:CORBF) and Fresenius Medical Care (NYSE:FMS)Comparing Global Cord Blood (NYSE:CORBF) and Fresenius Medical Care (NYSE:FMS)
americanbankingnews.com - April 13 at 4:32 AM
3 Medical Device Stocks With Solid Dividend Yield: CAH & Others3 Medical Device Stocks With Solid Dividend Yield: CAH & Others
zacks.com - April 11 at 10:36 AM
Reasons to Retain Fresenius Medical (FMS) in Your Portfolio NowReasons to Retain Fresenius Medical (FMS) in Your Portfolio Now
zacks.com - April 10 at 10:41 AM
Fresenius Medical Care AG (NYSE:FMS) Receives Consensus Rating of "Hold" from AnalystsFresenius Medical Care AG (NYSE:FMS) Receives Consensus Rating of "Hold" from Analysts
marketbeat.com - April 9 at 2:30 AM
Fresenius Medical Care (NYSE:FMS) Lowered to "Buy" at StockNews.comFresenius Medical Care (NYSE:FMS) Lowered to "Buy" at StockNews.com
marketbeat.com - April 5 at 11:10 PM
Fresenius Medical Care AG (NYSE:FMS) Short Interest Up 63.6% in MarchFresenius Medical Care AG (NYSE:FMS) Short Interest Up 63.6% in March
marketbeat.com - March 29 at 10:47 AM
Pacer Advisors Inc. Purchases 484,998 Shares of Fresenius Medical Care AG (NYSE:FMS)Pacer Advisors Inc. Purchases 484,998 Shares of Fresenius Medical Care AG (NYSE:FMS)
marketbeat.com - March 28 at 5:30 AM
Fresenius Medical (FMS) to Unveil Training on Augmented RealityFresenius Medical (FMS) to Unveil Training on Augmented Reality
zacks.com - March 25 at 12:11 PM
Fresenius Medical Care publishes 2023 joint Annual Report and Sustainability Report: Shaping the Future of Kidney CareFresenius Medical Care publishes 2023 joint Annual Report and Sustainability Report: Shaping the Future of Kidney Care
prnewswire.com - March 22 at 8:00 AM
Fresenius Medical Care launches "Augmented Reality" for training on Kidney Replacement Therapy deviceFresenius Medical Care launches "Augmented Reality" for training on Kidney Replacement Therapy device
prnewswire.com - March 19 at 8:00 AM
FMS Oct 2024 20.000 callFMS Oct 2024 20.000 call
finance.yahoo.com - March 17 at 8:20 AM
FMS Jul 2024 17.500 callFMS Jul 2024 17.500 call
finance.yahoo.com - March 17 at 1:45 AM
Fresenius Medical Care appoints Jörg Häring as new Management Board member responsible for Legal, Compliance and Human ResourcesFresenius Medical Care appoints Jörg Häring as new Management Board member responsible for Legal, Compliance and Human Resources
prnewswire.com - March 13 at 10:00 AM
Fresenius Medical (FMS) Divests Assets to Optimize PortfolioFresenius Medical (FMS) Divests Assets to Optimize Portfolio
zacks.com - March 11 at 10:46 AM
Fresenius Medical Care (ETR:FME) Will Pay A Larger Dividend Than Last Year At €1.19Fresenius Medical Care (ETR:FME) Will Pay A Larger Dividend Than Last Year At €1.19
finance.yahoo.com - March 9 at 9:42 AM
Why Dialysis Stocks Are Up This MorningWhy Dialysis Stocks Are Up This Morning
finance.yahoo.com - March 5 at 2:06 PM
Fresenius Medical Care Achieves Next Milestone in Portfolio Optimization Program, Announcing Sale of Dialysis Clinics in Brazil, Colombia, Chile, EcuadorFresenius Medical Care Achieves Next Milestone in Portfolio Optimization Program, Announcing Sale of Dialysis Clinics in Brazil, Colombia, Chile, Ecuador
prnewswire.com - March 5 at 10:10 AM
Novo Nordisk slips, dialysis stocks gain after kidney disease data for OzempicNovo Nordisk slips, dialysis stocks gain after kidney disease data for Ozempic
msn.com - March 5 at 9:06 AM
Broyhill - Fresenius Medical Care: Correctly Focused On Increasing Margins And ReturnsBroyhill - Fresenius Medical Care: Correctly Focused On Increasing Margins And Returns
seekingalpha.com - February 23 at 10:20 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

BlackRock New York Municipal Income Quality Trust

NYSE:BSE
BlackRock New York Municipal Income Quality Trust is a close ended fixed income mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the fixed income markets of United States. The fund primarily invests in investment grade municipal obligations exempt from federal income taxes and New York State and New York City personal income taxes. It was formerly known as BlackRock New York Insured Municipal Income Trust. BlackRock New York Municipal Income Quality Trust was formed in October 28, 2002 and is domiciled in United States.
Fresenius Medical Care logo

Fresenius Medical Care

NYSE:FMS
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.